Today: 15 May 2026
Browse Category

NASDAQ:GOOG.O 29 December 2025

Alphabet slips as year-end tech rally pauses; Fed minutes loom

Alphabet slips as year-end tech rally pauses; Fed minutes loom

Alphabet Class C shares fell 0.7% to $312.80 in early Monday trading as U.S. tech stocks slipped ahead of Tuesday’s Federal Reserve meeting minutes. Google’s Gemini Live voice mode rolled out a major update, but investors focused on rate expectations and year-end positioning. Microsoft edged up 0.1%, while Meta dropped 0.9%. Alphabet’s market value stood near $2.94 trillion.
29 December 2025
·

Stock Market Today

  • ABIVAX Société Anonyme Stock Slides Amid High Valuation and Losses
    May 15, 2026, 12:02 AM EDT. ABIVAX Société Anonyme (ENXTPA:ABVX) saw its stock fall 1.3% over one day, down 3.9% over a week, prompting investor scrutiny. Despite 55.4% revenue growth, the company posted a net loss of €336 million and trades at a price-to-book (P/B) ratio of 18x, compared with the French biotech average of 4.6x. The elevated P/B suggests expectations for future growth rather than current earnings, as ABIVAX remains unprofitable and relies on external borrowing. Analysts note shares trade 86% below fair value estimates based on projected cash flows, but high losses and negative return on equity (73.84%) weigh on sentiment. The stock's premium valuation reflects bullish views on drug pipeline progress, though risks remain amid ongoing clinical trials.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 15.05.2026

15 May 2026
LIVEMarkets rolling coverageStarted: May 15, 2026, 12:00 AM EDTUpdated: May 15, 2026, 12:10 AM EDT ABIVAX Société Anonyme Stock Slides Amid High Valuation and Losses May 15, 2026, 12:02 AM EDT. ABIVAX Société Anonyme (ENXTPA:ABVX) saw its stock fall 1.3% over one day, down 3.9% over a week, prompting investor scrutiny. Despite 55.4% revenue growth, the company posted a net loss of €336 million and trades at a price-to-book (P/B) ratio of 18x, compared with the French biotech average of 4.6x. The elevated P/B suggests expectations for future growth rather than current earnings, as ABIVAX remains unprofitable and relies on
US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

US Stock Market Today After Hours: Why the Dow Reclaimed 50,000 as AI Stocks Drove Wall Street Higher

15 May 2026
The Dow closed above 50,000 for the first time Thursday, rising 370 points as AI-driven gains lifted U.S. stocks to record highs. Cisco surged after raising its revenue outlook and announcing $9 billion in AI infrastructure orders, while Nvidia jumped 4.4% on U.S. approval to sell chips to China. Cerebras Systems soared 68% in its market debut. Not all chipmakers advanced, with Qualcomm, Intel, Sandisk, and Micron falling sharply.
Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

Xanadu Quantum Technologies Stock Gets Its First Public Earnings Test—and Losses Still Rule

15 May 2026
Xanadu Quantum Technologies reported first-quarter revenue of $2.8 million, up from $0.7 million a year earlier, but net loss widened to $20.6 million. Shares rose 1.9% to $15.13 in late U.S. trading before falling over 3% after hours. The company ended March with $272.5 million in cash and plans a $300 million at-the-market facility. Xanadu began trading on Nasdaq and TSX under XNDU on March 27.
Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

Sidus Space Stock Jumps After Q1 Revenue Rises 51%, But Losses Still Loom

15 May 2026
Sidus Space reported first-quarter revenue of $359,000, up 51% from a year earlier, and a net loss of $5.2 million, narrowing from $6.4 million. Shares rose about 12% after results. Cash stood at $27.3 million at March 31, down from $43.2 million at year-end. The company raised $58.5 million in a direct share offering after the quarter closed.
Go toTop